QUESTIONS?

Complete a short online visit with your health history, goals and measurements. A licensed U.S. provider reviews it, and if a GLP-1 is appropriate, your prescription is sent to a partner pharmacy and shipped to your door — usually within a few business days.

Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both GLP-1 and GIP receptors, which in clinical studies has been associated with greater average weight reduction. Your provider recommends one based on your history, tolerance and goals.

Published trials report average total body weight reductions in the range of roughly 15% for semaglutide and up to about 20% for tirzepatide over 68–72 weeks, combined with diet and activity changes. Individual results vary and are not guaranteed.

FaroRx compounded GLP-1 plans start at $159 per month, including the medication, provider oversight, supplies and free shipping. There are no membership or consultation fees on top of the plan price.

Compounded medications are typically paid out of pocket and are not billed to insurance. Many patients use HSA or FSA funds. We provide receipts on request.

No. Brand products such as Ozempic and Wegovy are FDA-approved medications made by their manufacturers. Compounded semaglutide is prepared by a licensed U.S. compounding pharmacy and is not an FDA-approved product. Compounded medications are prepared by a licensed U.S. compounding pharmacy and are not FDA-approved products. Treatment is prescribed only if a licensed provider determines it is appropriate for you.

Nausea, constipation, diarrhea, reflux, fatigue and injection-site irritation are the most commonly reported. They are usually mild and improve as your body adjusts to each dose step. Report anything severe or persistent to your care team right away.

Most patients notice reduced appetite and smaller portions within the first one to two weeks. Measurable weight change usually appears between weeks 4 and 12 as your dose is titrated upward.

Yes — GLP-1 treatment is a small weekly subcutaneous injection you give yourself, typically in the abdomen, thigh or upper arm. Your kit includes needles, alcohol swabs and step-by-step instructions, and your care team can walk you through the first dose.

Appetite usually returns and some weight regain is common after stopping. Many patients transition to a maintenance dose rather than stopping abruptly. Your provider will build a taper or maintenance plan with you.

Hair shedding reported on GLP-1s is usually telogen effluvium — a temporary response to rapid weight loss and lower calorie intake rather than a direct drug effect. Adequate protein, iron and a slower rate of loss help. FaroRx also offers hair treatments if shedding persists.

Providers generally consider a BMI of 30 or higher, or 27 and above with a weight-related condition such as high blood pressure, prediabetes or sleep apnea. Eligibility is a clinical decision made during your visit.

GLP-1 medications are not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN 2, active pancreatitis, or who are pregnant or breastfeeding. Disclose your full history during the intake.

FaroRx works with providers licensed in all 50 U.S. states and the District of Columbia. Availability of specific formulations can vary by state pharmacy regulations.

Medication ships cold-chain in discreet, unbranded packaging with tracking, at no additional cost. Most orders arrive within 2–5 business days of provider approval.

Some patients add lipotropic MIC + B12 support alongside a GLP-1. Combining treatments is only done when your provider reviews both and confirms it is appropriate for you.

The most common cause is androgenetic alopecia — genetically sensitive follicles that shrink under the influence of DHT, a byproduct of testosterone. Stress, thyroid problems, iron deficiency, rapid weight loss and some medications can also drive shedding.

The evidence-backed approach is to block the hormonal driver and support the follicle: Finasteride reduces DHT, while Minoxidil improves follicle blood flow and prolongs the growth phase. Consistent daily use is what determines results.

Shedding typically slows within about 3 months. Visible regrowth and density changes usually take 6 to 12 months of uninterrupted daily use, and photos taken monthly are the best way to track progress.

Topical Finasteride generally produces lower systemic exposure than the oral tablet, which some patients prefer. Both forms carry potential side effects, and your provider will discuss which fits your history.

A small percentage of men report reduced libido, erectile difficulty or decreased ejaculate volume. These are usually reversible on stopping. Report any mood changes or breast tenderness to your provider promptly.

Minoxidil widens blood vessels around the follicle and extends the anagen (growth) phase, producing thicker terminal hairs over time. It does not address DHT, which is why it is often paired with Finasteride.

Yes. A short "dread shed" in the first 2–8 weeks is common as follicles synchronize into a new growth cycle. It typically resolves and is not a reason to stop treatment.

Results are maintained only while you continue. Hair loss generally resumes within 3–6 months of stopping, and gains made are gradually lost.

Evidence is limited. One small 2009 study found an increase in DHT among rugby players taking creatine, but no study has shown creatine directly causes hair loss. If you are genetically predisposed, treating the DHT pathway matters more than avoiding creatine.

GLP-1 medications are not thought to attack follicles directly. Shedding on these medications is usually telogen effluvium from rapid weight loss and reduced nutrient intake, and it typically resolves as weight stabilizes.

Testosterone therapy raises DHT, which can accelerate genetic hair loss. Many men on TRT add Finasteride to protect the hairline. Discuss both treatments with your provider so they can be managed together.

Transplants relocate existing follicles and can restore a hairline, but they do not stop ongoing miniaturization. Most surgeons still recommend Finasteride afterward. Medication is the lower-cost, non-surgical first step.

FaroRx prescription hair plans are billed monthly with medication, provider review and shipping included — far below the cost of surgical restoration, which commonly runs into thousands of dollars.

Biotin only helps if you are actually deficient, which is uncommon. Supplements do not address DHT and are not a substitute for prescription treatment in androgenetic alopecia.

Oral Finasteride is not prescribed to women who may become pregnant. Female pattern hair loss is treated differently, and our providers will advise on appropriate options.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell uses to convert nutrients into energy and to support DNA repair. NAD+ therapy delivers the coenzyme by injection to raise circulating levels, which decline with age.

Patients commonly report improved energy, mental clarity, sleep quality and recovery. Research into NAD+ and cellular aging is ongoing, and individual outcomes vary. These are wellness protocols, not cures.

NAD+ is not an FDA-approved drug for longevity, anti-aging or energy indications. Compounded NAD+ is prepared by a licensed U.S. compounding pharmacy under a provider prescription. Compounded medications are prepared by a licensed U.S. compounding pharmacy and are not FDA-approved products. Treatment is prescribed only if a licensed provider determines it is appropriate for you.

Clinic IV infusions frequently run $300–$800 per session. FaroRx at-home subcutaneous NAD+ protocols are billed as a flat monthly plan including medication, supplies and provider oversight, which is substantially less per month.

Reported side effects are usually mild and dose-related: flushing, nausea, cramping or injection-site irritation, often reduced by injecting slowly. Your provider reviews your history and sets a conservative starting dose.

A typical protocol uses a loading phase of several doses per week for the first weeks, then a maintenance schedule. Your provider sets the exact frequency.

IV delivers a large dose at once; subcutaneous dosing delivers smaller amounts more frequently, which many patients tolerate better and can do at home without clinic visits.

Glutathione is the body's principal intracellular antioxidant, involved in neutralizing oxidative stress and supporting liver detoxification pathways. Levels fall with age, illness and stress.

They are used to support antioxidant capacity, recovery and skin brightness. Evidence for skin-lightening claims is limited, and FaroRx does not market glutathione as a cosmetic bleaching treatment.

Yes — subcutaneous glutathione is commonly prescribed for at-home use. Your kit includes syringes, alcohol swabs and dosing instructions, plus care-team support for your first injection.

Most patients tolerate them well. Possible effects include injection-site reactions, mild rash or, rarely, allergic reaction. People with asthma should discuss risks with their provider before starting.

Many longevity protocols pair them — NAD+ for cellular energy and glutathione for oxidative balance. Your provider will confirm whether combining them is appropriate for you.

These are generally not covered and are paid out of pocket. HSA and FSA cards are accepted by many patients; itemized receipts are available on request.

Some patients notice energy changes within the first two weeks of a loading phase; others take a full 4–8 week cycle. Results vary and are not guaranteed for any patient.

Sermorelin is a growth hormone-releasing hormone analog. Rather than replacing growth hormone, it signals your own pituitary gland to release it in natural pulses, mainly during sleep.

Synthetic HGH introduces the hormone directly and suppresses your own production. Sermorelin stimulates natural release, preserving the body's feedback loop, which is why many providers consider it a more physiologic approach.

Sermorelin reliably raises growth hormone and IGF-1 in responsive patients. Reported benefits include better sleep, recovery and body composition over 3–6 months. Effects vary by age, baseline levels and consistency.

The original branded product was withdrawn from the U.S. market for commercial reasons. Sermorelin today is prescribed as a compounded preparation from a licensed U.S. compounding pharmacy. Compounded medications are prepared by a licensed U.S. compounding pharmacy and are not FDA-approved products. Treatment is prescribed only if a licensed provider determines it is appropriate for you.

No. Sermorelin is a peptide that acts on the pituitary. It is not an anabolic steroid and does not act on androgen receptors.

Sermorelin does not directly raise testosterone. It works on the growth hormone axis. If low testosterone is your concern, your provider may discuss other options during your visit.

Dosing is individualized and typically given as a nightly subcutaneous injection before bed, when natural GH pulses are highest. Never adjust your dose without your provider.

Growth hormone output returns to your baseline over several weeks, and the benefits gradually fade. Because it does not shut down your own production, stopping is generally uneventful.

Commonly reported effects are injection-site redness, flushing, headache or transient water retention. It is not appropriate for people with active malignancy or certain pituitary conditions — full disclosure during intake is important.

TRT supplies testosterone from outside the body and suppresses natural production and sperm output. Stimulating protocols work with your own hormonal axis instead. Your provider will explain the trade-offs.

Your provider may request recent labs — commonly total and free testosterone, LH, FSH, estradiol and IGF-1 — before prescribing any hormone-related protocol.

Sleep quality and recovery often change within the first few weeks. Body composition changes generally require 3–6 months of consistent use alongside resistance training and adequate protein.

Peptides such as Sermorelin are prohibited by WADA and most sanctioned athletic bodies. If you compete in tested sport, do not start without checking your organization's rules.